The Lancet publishes phase 3 data on rocatinlimab in atopic dermatitis
The Lancet publishes rocatinlimab phase 3 results from the global, placebo-controlled ROCKET-IGNITE and ROCKET-HORIZON trials in moderate-to-severe atopic dermatitis.
Topic
The Lancet
Topic